--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
SGMT Sagimet Biosciences
- 4.950
- -0.120-2.37%
Close Dec 20 16:00 ET
- 4.990
- +0.040+0.81%
Post 20:01 ET
159.37MMarket Cap-4.25P/E (TTM)
5.250High4.920Low436.94KVolume4.930Open5.070Pre Close2.20MTurnover2.45%Turnover RatioLossP/E (Static)32.20MShares20.71052wk High0.93P/B88.28MFloat Cap2.39052wk Low--Dividend TTM17.83MShs Float20.710Historical High--Div YieldTTM6.51%Amplitude2.130Historical Low5.036Avg Price1Lot Size
Sagimet Biosciences Key Stats
Sagimet Biosciences Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Sagimet Biosciences Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data